Caregiver preference is a specific term used by the U.S. Food and Drug Administration (FDA). Broadly, caregiver preference is a statement reflecting how caregivers view and compare different features or characteristics of medical interventions. For example, the ability for a new treatment to be given at home rather than in a doctor’s office, clinic, or hospital versus how often the treatment must be given may be weighted differently by caregivers of different patient communities.
Opinions about the risks of side effects versus the benefits of a therapy or intervention may also differ. Capturing the caregiver preference (and patient preference) early in the therapy development process can help the researchers developing the therapy, the sponsor’s supporting the clinical trial, and the regulators.
U.S. Food and Drug Administration (FDA): Patient-Focused Drug Development Glossary
NCATS Toolkit for Patient-Focused Therapy Development: Empower Your Patient Community Voice
NCATS Toolkit for Patient-Focused Therapy Development: Determine Patients’ Needs